# OnCo record zumutor-biologics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/zumutor-biologics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "zumutor-biologics" ;
  schema:name "Zumutor Biologics"@en ;
  schema:description "Zumutor Biologics makes an antibody that blocks LLT1, a signal tumours use to switch off natural killer cells, part of the body's first-line immune defence. It is in a first trial in advanced solid tumours, alone and with an existing immunotherapy."@en ;
  schema:url <https://onco.cc/companies/zumutor-biologics/>, <https://zumutor.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://zumutor.com/>, <https://zumutor.com/about/>, <https://zumutor.com/wp-content/uploads/2024/06/Zumutor-Announces-First-Patient-Dosed_Final.pdf>, <https://clinicaltrials.gov/study/NCT06451497> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/checkpoint-inhibitor/> .